Literature DB >> 32249886

Self-assembly of paramagnetic amphiphilic copolymers for synergistic therapy.

Zhiliang Gao1, Weiwei Mu2, Yuan Tian1, Yimao Su1, Huanli Sun3, Gaorui Zhang4, Anning Li4, Dexin Yu4, Na Zhang2, Jingcheng Hao1, Yongjun Liu2, Jiwei Cui5.   

Abstract

Engineering nanoparticles (NPs) with multifunctionality has become a promising strategy for cancer theranostics. Herein, theranostic polymer NPs are fabricated via the assembly of amphiphilic paramagnetic block copolymers (PCL-b-PIEtMn), in which IR-780 and doxorubicin (DOX) were co-encapsulated, for magnetic resonance (MR) and near infrared fluorescence (NIRF) imaging as well as for photo thermal therapy (PTT)-enhanced chemotherapy. The synthesized amphiphilic paramagnetic block copolymers demonstrated high relaxivity (r1 = 7.05 mM-1 s-1). The encapsulated DOX could be released with the trigger of near infrared (NIR) light. In vivo imaging confirmed that the paramagnetic NPs could be accumulated effectively at the tumor sites. Upon the NIR laser irradiation, tumor growth was inhibited by PTT-enhanced chemotherapy. The advantages of the reported system lie in the one-step convergence of multiple functions (i.e., imaging and therapy agents) into a one delivery vehicle and the dual mode imaging-guided synergistic PTT and chemotherapy. This study represents a new drug delivery vehicle of paramagnetic NPs for visualized theranostics.

Entities:  

Year:  2020        PMID: 32249886     DOI: 10.1039/d0tb00405g

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

Review 1.  NIR-I Dye-Based Probe: A New Window for Bimodal Tumor Theranostics.

Authors:  Fan Zheng; Xueyan Huang; Jipeng Ding; Anyao Bi; Shifen Wang; Fei Chen; Wenbin Zeng
Journal:  Front Chem       Date:  2022-03-23       Impact factor: 5.221

Review 2.  Smart magnetic resonance imaging-based theranostics for cancer.

Authors:  Beatriz Brito; Thomas W Price; Juan Gallo; Manuel Bañobre-López; Graeme J Stasiuk
Journal:  Theranostics       Date:  2021-08-07       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.